FDA Inspection 1230349 — LifeCell Corporation

LifeCell Corporation — FEI 1000306051

The FDA completed an inspection of LifeCell Corporation on May 21, 2024 in Branchburg, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 21, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Branchburg, NJ (United States)